Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5K Sell
171
-18
-10% -$1.2K 0.01% 724
2026
Q1
$11.9K Buy
189
+17
+10% +$1.18K 0.01% 618
2025
Q4
$11.4K Sell
172
-86
-33% -$5.56K 0.01% 668
2025
Q3
$17.4K Sell
258
-24
-9% -$1.9K 0.01% 535
2025
Q2
$24.6K Buy
282
+24
+9% +$1.88K 0.02% 441
2025
Q1
$17.6K Buy
258
+32
+14% +$2.61K 0.02% 499
2024
Q4
$17.6K Buy
+226
New +$16.7K 0.02% 487

Other funds holding DXCM

WPG Advisers's DXCM Position: Q2 2026 in Review

WPG Advisers reduced its DexCom (DXCM) stake by 9.5% in Q2 2026, selling an estimated $1.2K and leaving 171 shares worth $11.5K. The position accounts for 0.01% of the portfolio, ranked #724.

WPG Advisers first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $24.6K in Q2 2025. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • WPG Advisers held 171 shares of DexCom worth $11.5K as of Q2 2026.
  • WPG Advisers sold 18 DexCom shares in Q2 2026, an estimated $1.2K.
  • DexCom made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #724 holding.
  • WPG Advisers first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's DexCom position peaked at $24.6K in Q2 2025.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.